Antibody therapy of lymphoma

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.6, 2001-06, pp. : 953-961

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frequent expression of CD30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 166-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Rituximab and other emerging monoclonal antibody therapies for lymphoma

By Tobinai Kensei

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 289-302

Informa Healthcare

Access to resources Recommend Favorite

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 4, 2000-12 ,pp. : 303-312

Bentham Science Publishers

Access to resources Recommend Favorite

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 1, 2000-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite